Hurlburt Elizabeth — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Hurlburt Elizabeth is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $2.28M.
Profile
Elizabeth Hurlburt is the Chief Operating Officer and Executive Vice President of CorMedix Inc., a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases. She has been involved in the company's operations and strategic initiatives, particularly in the commercialization of its product, DefenCath.
Elizabeth Hurlburt is the Chief Operating Officer and Executive Vice President of CorMedix Inc., a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases. She has been involved in the company's operations and strategic initiatives, particularly in the commercialization of its product, DefenCath.…
Has Hurlburt Elizabeth been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 3 open-market sales ($2.28M) across all tracked filings.
Where can I see all of Hurlburt Elizabeth's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
